Anuradha Dhanasekaran

Dr. Anuradha Dhanasekaran

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2019 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
MSMayank Sharma
Mayank Sharma
JPJuhee Pandya
Juhee Pandya
DPDivyangkumar M. Patel
Divyangkumar M. Patel
RVRuturajsinh M. Vala
Ruturajsinh M. Vala
VRV. Ramkumar
V. Ramkumar
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
A one-pot procedure for the preparation of functionalized 1,4-dihydropyridines by three-component reaction using substituted heterocyclic aldehydes, ammonium acetate, and substituted β-ketoesters catalyzed by L-proline was described. Present protocol offers excellent yield up to 92%, flexibility with different substitution, convenient operation, and eco-friendliness. The synthesized products were confirmed by 1H-NMR, 13C-APT, and IR spectroscopy. Herein, final confirmation of the targeted motif was made by X-ray single-crystal analysis of representative compounds (4f, 4j, 4k, 4l, and 4o). The chemically synthesized compounds were evaluated for the antiproliferative activity by cell viability (MTT) assay and dual AO/EB (acridine orange/ethidium bromide)-staining method against human A549 lung cancer cell lines. The viability of the treated cell was evaluated adopting MTT assay. According to associated changes in cell membranes during the process of apoptosis, a clear difference was observed between normal cells, early and late apoptotic cells, and necrotic cells. All compounds were found effective against Saccharomyces cerevisiae which was confirmed by increased reactive oxygen species production and DNA damage as compared to untreated yeast cell culture. Altogether, these compounds showed promising hope for application in pharmaceutical aid against yeast infections.

1 October 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
TPTarun Pant
Tarun Pant
MJMatea Juric
Matea Juric
ZBZeljko J. Bosnjak
Zeljko J. Bosnjak
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran
Advances in the field of regenerative medicine and tissue engineering over the past few decades have paved the path for cell-free therapy. Numerous stem cell types, including mesenchymal stem cells (MSCs), have been reported to impart therapeutic effects via paracrine secretion of exosomes. The underlying factors and the associated mechanisms contributing to these MSC-derived exosomes' protective effects are, however, poorly understood, limiting their application in the clinic. The exosomes exhibit a diversified repertoire of functional non-coding RNAs (ncRNAs) and have the potential to transfer these biologically active transcripts to the recipient cells, where they are found to modulate a diverse array of functions. Altered expression of the ncRNAs in the exosomes has been linked with the regenerative potential and development of various diseases, including cardiac, neurological, skeletal, and cancer. Also, modulating the expression of ncRNAs in these exosomes has been found to improve their therapeutic impact. Moreover, many of these ncRNAs are expressed explicitly in the MSC-derived exosomes, making them ideal candidates for regenerative medicine, including tissue engineering research. In this review, we detail the recent advances in regenerative medicine and summarize the evidence supporting the altered expression of the ncRNA repertoire specific to MSCs under different degenerative diseases. We also discuss the therapeutic role of these ncRNA for the prevention of these various degenerative diseases and their future in translational medicine.

1 January 2021 in Life Sciences
Verified
Journal Article
Closed access
YCYamini Chandramohan
Yamini Chandramohan
KJKavya Jeganathan
Kavya Jeganathan
SSSanjana Sivanesan
Sanjana Sivanesan
PKPavani Koka
Pavani Koka
TATrikkur Madom Seetaraman Amritha
Trikkur Madom Seetaraman Amritha
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran

20 August 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
PKPavani Koka
Pavani Koka
RMReddy Sailaja Mundre
Reddy Sailaja Mundre
RRRohini Rangarajan
Rohini Rangarajan
YCYamini Chandramohan
Yamini Chandramohan
RSRaghunandha Kumar Subramanian
Raghunandha Kumar Subramanian
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran

28 November 2018 in Diabetes & Vascular Disease Research
Verified
Journal Article
Open access
TPTarun Pant
Tarun Pant
MMManoj K. Mishra
Manoj K. Mishra
Xiaowen BaiXiaowen Bai
Xiaowen Bai
ZGZhi-Dong Ge
Zhi-Dong Ge
ZBZeljko J. Bosnjak
Zeljko J. Bosnjak
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran
This study aims to investigate the altered expression signature of long non-coding RNAs, mRNAs and deregulated pathways related to diabetic cardiomyopathy disease pathogenesis. We utilize the previously established in vitro diabetic cardiomyopathy model of human induced pluripotent stem cell–derived human cardiomyocytes to perform long non-coding RNA and mRNA expression analysis on glucose (11 mM), endothelin-1 (10 nM) and cortisol (1 µM) stimulated human induced pluripotent stem cell–derived human cardiomyocytes to interrogate diabetic cardiomyopathy associated RNA expression profile. Out of 20,730 mRNAs and 40,173 long non-coding RNAs being screened, 2046 long non-coding RNAs and 1582 mRNAs were differentially regulated (fold change > 2, p < 0.05) between diabetic cardiomyopathy and control group, of which more than half were intergenic and antisense long non-coding RNAs. Most of the coding transcripts were associated with processes like inflammation, structural reorganization, metabolism, smooth muscle contraction, focal adhesion and repair contributing towards the development of diabetic cardiomyopathy. The subgroup analysis further revealed 411 long non-coding RNAs being co-expressed with neighbouring genes. However, our coding–non-coding co-expression analysis showed an overall 48,155 co-expression network connections. In addition to that, the long non-coding RNAs with highest network connections were profoundly enriched for focal adhesion, cell-matrix adhesion and muscle contraction. These results provide comprehensive data about the pathways and regulatory mechanisms associated with diabetic cardiomyopathy and indicate that long non-coding RNAs may play a crucial role in diabetic cardiomyopathy.

11 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JDJeeva Jothi D
Jeeva Jothi D
MDMuthu Dhanraj
Muthu Dhanraj
SSShanmugam Solaiappan
Shanmugam Solaiappan
SSSanjana Sivanesan
Sanjana Sivanesan
MKMichael Kron
Michael Kron
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran
A hallmark of chronic infection with lymphatic filarial parasites is the development of lymphatic disease which often results in permanent vasodilation and lymphedema, but all of the mechanisms by which filarial parasites induce pathology are not known. Prior work showed that the asparaginyl-tRNA synthetase (BmAsnRS) of Brugia malayi, an etiological agent of lymphatic filariasis, acts as a physiocrine that binds specifically to interleukin-8 (IL-8) chemokine receptors. Endothelial cells are one of the many cell types that express IL-8 receptors. IL-8 also has been reported previously to induce angiogenesis and vasodilation, however, the effect of BmAsnRS on endothelial cells has not been reported. Therefore, we tested the hypothesis that BmAsnRS might produce physiological changes in endothelial by studying the in vitro effects of BmAsnRS using a human umbilical vein cell line EA.hy926 and six different endothelial cell assays. Our results demonstrated that BmAsnRS produces consistent and statistically significant effects on endothelial cells that are identical to the effects of VEGF, vascular endothelial growth factor. This study supports the idea that new drugs or immunotherapies that counteract the adverse effects of parasite-derived physiocrines may prevent or ameliorate the vascular pathology observed in patients with lymphatic filariasis.